1062 / 1224
TAKE HOME MESSAGES
•
Investigate your uncertainty budgets for your specific
clinical workflows and report them
•
Clinical impact depends on dose level (EQD2,
a/b
) and
shape of the dose-response curve
•
Observed dose-response curves in the literature are subject
to (unreported) uncertainties
•
Uncertainty reduction can help in individual cases near
OAR dose limits and below target planning aims